CGB Stock Overview

Cann Global Limited engages in the production and distribution of medicinal cannabis medications, natural foods, and cosmeceuticals in Australia and internationally. More details

CGB fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	6/6
Dividends	0/6

Risk Analysis

Earnings have declined by 7.9% per year over past 5 years

Does not have a meaningful market cap (A$5M)

Makes less than USD$1m in revenue (A$562K)

Shares are highly illiquid

+ 1 more risk

My Notes

Capture your thoughts, links and company narrative

Cann Global Limited Competitors

Epsilon Healthcare

ASX:EPN

AU$7.2m

Ecofibre

ASX:EOF

AU$10.2m

Bod Science

ASX:BOD

AU$4.3m

Avecho Biotechnology

ASX:AVE

AU$9.5m

Price History & Performance

Summary of share price highs, lows and changes for Cann Global
Historical stock prices
Current Share Price	AU$0.021
52 Week High	AU$0.075
52 Week Low	AU$0.017
Beta	1.03
1 Month Change	0%
3 Month Change	0%
1 Year Change	-72.00%
3 Year Change	-94.00%
5 Year Change	-98.38%
Change since IPO	-99.60%

Recent updates

What Can We Make Of Cann Global's (ASX:CGB) CEO Compensation?

Jan 16

Shareholder Returns

	CGB	AU Pharmaceuticals	AU Market
7D	0%	-4.9%	-2.7%
1Y	-72.0%	-9.3%	6.5%

Return vs Industry: CGB underperformed the Australian Pharmaceuticals industry which returned 61.8% over the past year.

Return vs Market: CGB underperformed the Australian Market which returned 9.6% over the past year.

Price Volatility

Is CGB's price volatile compared to industry and market?
CGB volatility
CGB Average Weekly Movement	n/a
Pharmaceuticals Industry Average Movement	10.3%
Market Average Movement	8.0%
10% most volatile stocks in AU Market	16.8%
10% least volatile stocks in AU Market	3.1%

Stable Share Price: CGB has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine CGB's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2007	n/a	Sholom Feldman	www.canngloballimited.com

Cann Global Limited engages in the production and distribution of medicinal cannabis medications, natural foods, and cosmeceuticals in Australia and internationally. It operates through Hemp and Medical Cannabis Products, and Mining Exploration and Evaluation segments. The company grows and cultivates hemp and medical cannabis products; provides nutritious and vitamin packed plant-based foods under the Grass Roots brand; and offers skincare products under the Fuss Pot brand.

Cann Global Limited Fundamentals Summary

How do Cann Global's earnings and revenue compare to its market cap?
CGB fundamental statistics
Market cap	AU$5.44m
Earnings (TTM)	-AU$8.22m
Revenue (TTM)	AU$562.34k

9.7x

P/S Ratio

-0.7x

P/E Ratio

Is CGB overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
CGB income statement (TTM)
Revenue	AU$562.34k
Cost of Revenue	AU$640.53k
Gross Profit	-AU$78.20k
Other Expenses	AU$8.14m
Earnings	-AU$8.22m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)	-0.032
Gross Margin	-13.91%
Net Profit Margin	-1,461.39%
Debt/Equity Ratio	0%

How did CGB perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2022/12/28 08:21
End of Day Share Price	2022/09/30 00:00
Earnings	2022/06/30
Annual Earnings	2022/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Cann Global Limited is covered by 0 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution